Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Deals of the day-Mergers and acquisitions

Published 18/10/2018, 09:08 pm
© Reuters.  Deals of the day-Mergers and acquisitions

Oct 18 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1000 GMT on Thursday:

** Hungarian holding companies Konzum KONU.BU and Opus Global OPUSG.BU announced a plan to merge, creating a combined entity with a market capitalisation of about 350 billion to 400 billion forints ($1.25 billion to $1.43 billion). German copper products maker Wieland-Werke has submitted concessions in an attempt to allay European Union antitrust concerns over its plan to buy a flat rolled copper products business from Aurubis AG NAFG.DE , Europe's biggest copper smelter. Industrial gases group Praxair (NYSE:PX) PX.N and Linde LIN1.DE are set to win U.S. antitrust approval for their planned $86 billion merger, clearing the last major hurdle for the deal, German monthly Manager Magazin reported. North African-focused oil and gas company SDX Energy SDX.L said that talks to buy some of BP's BP.L Egyptian assets have been abandoned. Greece expects to get final bids for a majority stake in its biggest oil refiner Hellenic Petroleum HEPr.AT next month after a key regulatory decision on the process, a source close to the sale said. Takeda Pharmaceutical Co Ltd 4502.T said Japan's Fair Trade Commission had approved its $62 billion acquisition of Shire Plc SHP.L , bringing the Japanese firm closer to sealing a deal that will make it a global top 10 drugmaker. Freenet FNTGn.DE is not considering buying further shares in German electronics retailer Ceconomy CECG.DE , WirtschaftsWoche magazine quoted the telecoms company's chief executive as saying. French supermarket retailer Casino CASP.PA has agreed to sell a portfolio of real estate assets for 180 million euros ($207 million), as it continues an asset-sale programme to cut debts which have concerned some investors. Novartis AG NOVN.S will acquire U.S.-based cancer drugmaker Endocyte Inc ECYT.O for $2.1 billion in cash as the Swiss drugmaker expands its radiopharmaceuticals business, the companies said. Indian business conglomerate Tata Group has held preliminary discussions to buy a large stake in debt-laden Jet Airways (India) Ltd JET.NS , the Times of India reported. Private equity giant Blackstone (NYSE:BX) Group BX.N has quit a takeover battle for Australian office-block owner Investa Office Fund IOF.AX after it was gazumped by Canadian landlord Oxford Properties Group's A$3.35 billion ($2.4 billion) bid.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.